Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Q: What does CUSIP 78667J108 represent in this 13F holders report?

CUSIP 78667J108 is the security identifier for SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") used to aggregate holder disclosures.

Q: How many institutions held SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in Q2 2022?

188 institutional investors reported SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 78667J108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
Shares outstanding: 62,650,155
Total 13F shares: 51,071,239
Share change: +1,265,231
Total reported value: $1,649,759,751
Put/Call ratio: 42%
Price per share: $32.30
Number of holders: 188
Value change: +$39,700,428
Number of buys: 90
Number of sells: 99

Quarterly Holders Quick Answers

What is CUSIP 78667J108?
CUSIP 78667J108 identifies SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 78667J108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	11%	6,995,000	$231,535,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	9%	5,631,512	$186,403,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	7.4%	4,625,003	$153,088,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	4.9%	3,052,404	$101,034,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	4.5%	2,835,356	$93,850,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	4.4%	2,754,216	$91,163,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.4%	2,158,504	$71,446,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	2.6%	1,613,650	$53,412,000	—	31 Mar 2022	13F
Boxer Capital, LLC	13F	Company	1.7%	1,094,000	$36,211,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.6%	1,029,953	$34,092,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	1.5%	926,536	$30,668,000	—	31 Mar 2022	13F
Palo Alto Investors LP	13F	Company	1.4%	851,719	$28,192,000	—	31 Mar 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	1.3%	844,652	$27,958,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.3%	815,621	$26,996,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	1.2%	750,000	$24,825,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	716,682	$23,722,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	1.1%	704,819	$23,377,568	—	31 Mar 2022	13F
Deep Track Capital, LP	13F	Company	1.1%	675,000	$22,343,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	1%	634,033	$20,986,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.92%	579,342	$19,177,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.9%	565,122	$18,705,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.74%	461,234	$15,266,845	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.7%	441,000	$14,597,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.56%	352,623	$11,672,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.53%	331,746	$10,981,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.5%	313,457	$10,376,000	—	31 Mar 2022	13F
Integral Health Asset Management, LLC	13F	Company	0.5%	311,000	$10,294,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.48%	301,728	$9,987,000	—	31 Mar 2022	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.47%	292,086	$9,668,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.43%	267,945	$8,869,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.42%	262,434	$8,686,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	0.4%	249,907	$8,272,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.38%	241,079	$7,980,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.36%	226,603	$7,614,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.3%	189,290	$6,265,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.29%	180,979	$5,989,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	0.29%	180,306	$5,968,000	—	31 Mar 2022	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.28%	176,949	$5,857,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.28%	174,548	$5,778,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.27%	171,030	$5,664,000	—	31 Mar 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.27%	170,910	$5,657,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.26%	162,899	$5,392,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.26%	162,212	$5,369,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	153,686	$5,087,000	—	31 Mar 2022	13F
Aristotle Atlantic Partners, LLC	13F	Company	0.24%	152,103	$5,035,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.21%	132,478	$4,385,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.2%	125,300	$4,147,000	—	31 Mar 2022	13F
Gamma As Sector	13F	Individual	0.19%	118,476	$3,922,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.18%	114,616	$3,794,000	—	31 Mar 2022	13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	13F	Company	0.18%	113,001	$3,740,000	—	31 Mar 2022	13F

Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q2 2022

As of 30 Jun 2022, Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by 188 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,071,239 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, MARSHALL WACE, LLP, JPMORGAN CHASE & CO, and Point72 Asset Management, L.P.. This page lists 189 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

190

Q2 2022 holders

188

Holder diff

-2

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.